Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.


|Includes:Geron Corporation (GERN)

Nice surprise today with a GE-Geron business deal. This could revolutionize how clinical trials are done; testing drugs on human cells instead of animals. This could potentially save billions a year for pharma/biotech in clinical trial costs and thus reducing the expense of drugs for you and I. Not a surprise to see Feuerstein bashing as he does all biotechs. Can't blame the puppet when the master pulls the strings though. He is of no importance to the ultimate performance of the stock.

Disclosure: Long GERN

Stocks: GERN